INVITES BIOCORE CO., LTD
인바이츠바이오코아(주)
Verification summary
- Legal name (EN / KO)
- INVITES BIOCORE CO., LTD (인바이츠바이오코아(주))
- Business registration no.
106-81-99931(1068199931)- Stock listing
- KONEX listed · stock code
216400· DART00537221 - 12-month KONEPS contracts
1contract · KRW 71,500,000- Live NTS tax status
- Check live NTS status ↗
- verified_at
How to verify a Korean company (BRN format, live NTS status, DART & KONEPS) →
- English name (as registered with DART)
- INVITES BIOCORE CO., LTD
- Korean legal name
- 인바이츠바이오코아(주)
- Alternate names
- 인바이츠바이오코아
- Market
KONEX- Stock Code
216400- DART Corp Code
00537221- CEO
- 신승수
- Business Registration No.
106-81-99931- Corporate Registration No.
1101112250077- Established Date
2001-05-30- Fiscal Month
12- KSIC Industry Code
70113- Address (KO)
- 서울특별시 금천구 디지털로9길 33
- Homepage
- https://www.bio-core.com/ ↗
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:19 UTCAnnual Financial Summary (KRW)
2025
Basis CFS (Consolidated)
Currency KRW
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 16,643,930,380 | KRW 12,907,443,606 |
| Operating Income (영업이익) | KRW 218,446,622 | KRW -553,325,438 |
| Net Income (당기순이익) | KRW -8,301,965,086 | KRW -10,753,726,231 |
| Total Assets (자산총계) | KRW 82,778,281,611 | KRW 98,007,229,408 |
| Total Liabilities (부채총계) | KRW 80,123,552,796 | KRW 84,144,201,573 |
| Total Equity (자본총계) | KRW 2,654,728,815 | KRW 13,863,027,835 |
2026-11-08 02:22 UTCRecent DART Filings (Last 90 Days, up to 20)
| Filed | Theme | Filing (EN) | Filer |
|---|---|---|---|
| No filings in the last 90 days. | |||
Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:19 UTCPublic procurement (last 12 months)
Contracts first signed in the last 12 months.
The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total.
- Aggregation Period
2025-11-08to2026-11-07(basis:original_signed_date)- 12-Month Procurement Amount
- KRW 71,500,000
- 12-Month Contract Count
1(Joint contracts:0)- Unit-Price (Framework) Contracts (Reported Separately)
0contracts | Ceiling: KRW 0
By Procurement Category
| Category | Contracts | 12M Counted Amount (KRW) |
|---|---|---|
| Goods (물품) | 0 | KRW 0 |
| Construction (공사) | 0 | KRW 0 |
| Services (용역) | 1 | KRW 71,500,000 |
| Foreign Procurement (외자) | 0 | KRW 0 |
By Contract Type
| Contract Type | Contracts | Supplier Share / Current Amount (KRW) | Total Contract Ceiling / Multi-year Total (KRW) |
|---|---|---|---|
| Lump-sum / Standard (총액·일반) | 1 | KRW 71,500,000 | KRW 71,500,000 |
| Multi-year / Continuing (장기·계속비) | 0 | KRW 0 | KRW 0 |
| Unit-price / Framework Ceiling (단가·제3자단가 — excluded from 12M total) | 0 | KRW 0 | KRW 0 |
| Unclassified / Zero-amount (기타) | 0 | KRW 0 | KRW 0 |
Top 5 Government Buyers
| Buyer (Korean Legal Name) | Agency Code | Contracts | 12M Amount (KRW) |
|---|---|---|---|
| 주식회사 히포티앤씨 | Z061560 | 1 | KRW 71,500,000 |
Recent Contracts (up to 1)
| Signed Date | Contract No. (KONEPS) | Contract Title (KO) | Category / Type | Buyer (KO) | Contract Amount (KRW) | Participation |
|---|---|---|---|---|---|---|
| 2026-09-02 | R26TA02188730 ↗ |
교통사고 후 우울증 환자 대상 디지털치료제(BlueKare) 시범보급・실증 연구 수행을 위한 CRO 용역 | services / lump_sum |
주식회사 히포티앤씨 | KRW 71,500,000 | Sole (100%) |